# Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia

> **NCT00115804** · PHASE3 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 6 (actual)

## Conditions studied

- Juvenile Primary Fibromyalgia Syndrome (JPFS)
- Fibromyalgia

## Interventions

- **DRUG:** Fluoxetine

## Key facts

- **NCT ID:** NCT00115804
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115804

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115804, "Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00115804. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*